| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500660 |
NSE Symbol : GLAXO |
P/E(TTM) : 45.52 |
|
ISIN Demat : INE159A01016 |
Div & Yield% : 2.12 |
EPS(TTM) : 55.87 |
|
Book Value(₹) : 100.52 |
Market Cap(₹Cr) : 43,081.65 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 973.63 | 804.83 | 966.08 | 946.36 | 1,000.05 | 811.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 973.63 | 804.83 | 966.08 | 946.36 | 1,000.05 | 811.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 33.91 | 43.76 | 39.46 | 35.06 | 36.88 | 35.85 |
| Total Income | 1,007.54 | 848.59 | 1,005.54 | 981.42 | 1,036.93 | 846.85 |
| Total Expenditure | 638.95 | 554.08 | 635.34 | 656.18 | 681.10 | 581.58 |
| PBIDT | 368.59 | 294.51 | 370.20 | 325.24 | 355.83 | 265.27 |
| Interest | 0.51 | 0.42 | 0.58 | 0.09 | 0.27 | 0.37 |
| PBDT | 368.08 | 294.09 | 369.62 | 325.15 | 355.56 | 264.90 |
| Depreciation | 17.43 | 15.52 | 14.72 | 18.80 | 16.86 | 16.41 |
| Tax | 95.21 | 73.85 | 89.34 | 73.05 | 97.46 | 63.33 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.44 | 0.02 | 5.42 | 4.72 | -7.45 | 3.51 |
| Reported Profit After Tax | 255.00 | 204.70 | 260.14 | 228.58 | 248.69 | 181.65 |
| Extra-ordinary Items | 1.92 | 0.00 | 0.00 | 0.00 | 3.34 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 253.08 | 204.70 | 260.14 | 228.58 | 245.35 | 181.65 |
| EPS (Unit Curr.) | 14.92 | 12.08 | 15.35 | 13.49 | 14.45 | 10.72 |
| EPS (Adj) (Unit Curr.) | 14.92 | 12.08 | 15.35 | 13.49 | 14.45 | 10.72 |
| Calculated EPS (Unit Curr.) | 15.05 | 12.08 | 15.36 | 13.49 | 14.68 | 10.72 |
| Calculated EPS (Adj) (Unit Curr.) | 15.05 | 12.08 | 15.36 | 13.49 | 14.68 | 10.72 |
| Calculated EPS (Ann.) (Unit Curr.) | 60.21 | 48.33 | 61.42 | 53.97 | 58.72 | 42.89 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 60.21 | 48.33 | 61.42 | 53.97 | 58.72 | 42.89 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 240.00 | 120.00 | 0.00 |
| Equity | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 37.86 | 36.59 | 38.32 | 34.37 | 35.58 | 32.71 |
| PBDTM(%) | 37.80 | 36.54 | 38.26 | 34.36 | 35.55 | 32.66 |
| PATM(%) | 26.19 | 25.43 | 26.93 | 24.15 | 24.87 | 22.40 |